Experience with Application of HF400:a Recently Developed Machine for Continuous Renal Replecement Therapy

龚德华,季大玺,陶静,徐斌,任冰,刘云,张一丹,金中华,黎磊石
DOI: https://doi.org/10.3969/j.issn.1006-298x.2004.04.006
2004-01-01
Abstract:Objective:In this report, we described our experience with the application of a recently developed machine for continuous renal replacement therapy(CRRT). Methodology:Twenty-four patients in the clinical ward of the institute were enrolled in this study. All of the patients were indicated for the application of CRRT, with the clinical development of acute renal failure(ARF) or chronic renal failure(CRF) complicated with heart failure or lung edema. Continuous veno-venous hemofiltration(CVVH) was performed in these patients using HF400 CRRT machine and AV600s filters. The flow rate of substitute fluid was 3-4L/h, duration of each session of CRRT lasted for 6-8 hours. Before and after each session of CVVH, serum level of urea, creatinine, uric acid, and electrolytes such as potassium, sodium and chloride were evaluated. Prescribed treatment dose, net ultrafiltration volume, and delivered treatment dose, delivered net ultrafiltration volume were recorded. Results:All the patients tolerated CVVH therapy well. Reduction rate of serum urea, creatinine, uric acid after CVVH were (42±11)%,(41±12)% and (56±8)%, respectively. Serum electrolytes levels were maintained in stable range. The percentage of difference between prescribed dose(28.6±3.7L) and delivered dose(27.8±3.4L) was 2.5%(median,95% range 0.6%-7.2%). The percentage of difference between prescribed net ultrafiltration volume( 2 748±969 ml) and delivered net ultrafiltration volume[( 2 554±819) ml] was 5.4%(median, 95% range 1.9%-13.6%). The deviation rate of total volume control was 0.52%( median,95% range 0.12%-1.0%). Conclusion:This new model of HF400 for CRRT is safe and effective, with excellent accuracy of volume control in clinical applications.
What problem does this paper attempt to address?